Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia

Ann Hepatol. 2014 Nov-Dec;13(6):843-4.

Authors

Ilker I Balkan¹, Selma Bozcan², Mucahit Yemisen¹, Zekayi Kutlubay³, Resat Ozaras¹

Affiliations

¹ Infectious Diseases Dept. Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.
² Internal Medicine Dept. Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.
³ Dermatology Dept. Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

PMID: 25332274

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anemia, Aplastic / complications
Anemia, Aplastic / therapy*
Antiviral Agents / therapeutic use*
Hematopoietic Stem Cell Transplantation*
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / drug therapy*
Humans
Interferon-alpha / therapeutic use*
Male
Oligopeptides / therapeutic use*
Polyethylene Glycols / therapeutic use*
Recombinant Proteins / therapeutic use
Ribavirin / therapeutic use*
Young Adult

Substances

Antiviral Agents
Interferon-alpha
Oligopeptides
Recombinant Proteins
Polyethylene Glycols
Ribavirin
telaprevir
peginterferon alfa-2a